Sodium nitroprusside but not molsidomine may be used for antipsychotic augmentation in treatment resistant schizophrenia

Autor: Titulaer, J., Malmerfelt, A., Marcus, M.M., Perrone, A., Alken, G., Svensson, T.H.
Zdroj: In European Neuropsychopharmacology 2019 29 Supplement 1:S424-S425
Databáze: ScienceDirect